Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Toan, Nguyen L ^a,b   Sy, Bui T ^b,e   Song, Le H ^c   Luong, Hoang V ^b   Binh, Nguyen T ^b   Binh, Vu Q ^b   Kandolf, Reinhard ^a   Velavan, Thirumalaisamy P ^a   Kremsner, Peter G ^a,d   Bock, C Thomas ^a,e  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^c Tran Hung Dao Hospital   (Viet Nam)

^d CERMEL Centre de Recherche Médicale de Lambaréné   (Gabon)

^e ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Co infection; Erythrovirus; Gabonese children; Human parvovirus B19; Malaria; P. falciparum

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ANEMIA; ARTICLE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; ETHNIC GROUP; FEMALE; GABON; GABONESE; GENETIC ANALYSIS; GENETIC DISTANCE; GENOTYPE; HEMATOCRIT; HUMAN; HUMAN PARVOVIRUS B19; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANISMAL INTERACTION; PARASITEMIA; PATHOGENESIS; PHYLOGENETIC TREE; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SEROPREVALENCE; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

EID: 84883246394     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-375     Document Type: Article

References (51)

1. Koukouikila-Koussounda F, Ntoumi F, Ndounga M, Tong HV, Abena AA, Velavan TP. Genetic evidence of regulatory gene variants of the STAT6, IL10R and FOXP3 locus as a susceptibility factor in uncomplicated malaria and parasitaemia in Congolese children. Malar J 2013, 12:9. 10.1186/1475-2875-12-9, 3547756, 23297791.
2. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002, 415(6872):673-679. 10.1038/415673a, 11832955.
3. Lortholary O, Eliaszewicz M, Dupont B, Courouce AM. Parvovirus B19 infection during acute Plasmodium falciparum malaria. Eur J Haematol 1992, 49(4):219.
4. Wildig J, Mueller I, Kiniboro B, Maraga S, Siba P, Cossart Y. Seroprevalence of antibodies to parvovirus B19 among children in Papua New Guinea. Am J Trop Med Hyg 2007, 77(2):354-357.
5. Bonsch C, Kempf C, Mueller I, Manning L, Laman M, Davis TM, Ros C. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication. PLoS Negl Trop Dis 2010, 4(4):e669. 10.1371/journal.pntd.0000669, 2860510, 20436917.
6. Ingrassia F, Gadaleta A, Maggi P, Pastore G. Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection. BMC Infect Dis 2010, 10:87. 10.1186/1471-2334-10-87, 2858734, 20359364.
7. Jones PH, Pickett LC, Anderson MJ, Pasvol G. Human parvovirus infection in children and severe anaemia seen in an area endemic for malaria. J Trop Med Hyg 1990, 93(1):67-70.
8. Duedu KO, Sagoe KW, Ayeh-Kumi PF, Affrim RB, Adiku T, Huat LB. The effects of co-infection with human parvovirus B19 and Plasmodium falciparum on type and degree of anaemia in Ghanaian children. Asian Pac J Trop Biomed 2013, 3(2):129-139. 10.1016/S2221-1691(13)60037-4, 3627173, 23593592.
9. Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 2000, 124(3):449-457. 10.1017/S0950268899003817, 2810931, 10982069.
10. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002, 15(3):485-505. 10.1128/CMR.15.3.485-505.2002, 118081, 12097253.
11. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004, 350(6):586-597. 10.1056/NEJMra030840, 14762186.
12. Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol 2000, 12(4):289-294. 10.1097/00002281-200007000-00010, 10910181.
13. Colmegna I, Alberts-Grill N. Parvovirus B19: its role in chronic arthritis. Rheum Dis Clin North Am 2009, 35(1):95-110. 10.1016/j.rdc.2009.03.004, 19480999.
14. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010, 52(4):514-522. 10.1016/j.jhep.2010.01.014, 20207438.
15. Bock CT, Klingel K, Kandolf R. Human parvovirus B19-associated myocarditis. N Engl J Med 2010, 362(13):1248-1249. 10.1056/NEJMc0911362, 20357294.
16. Dingli D, Pfizenmaier DH, Arromdee E, Wennberg P, Spittell PC, Chang-Miller A, Clarke BL. Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 2000, 356(9226):312-314.
17. Barah F, Vallely PJ, Chiswick ML, Cleator GM, Kerr JR. Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 2001, 358(9283):729-730. 10.1016/S0140-6736(01)05905-0, 11551584.
18. He Z, Zhuang H, Wang X, Song S, Dong Q, Yan J, Buehring GC, Luo G. Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection. J Med Virol 2003, 69(1):59-65. 10.1002/jmv.10248, 12436478.
19. Toan NL, le Song H, Kremsner PG, Duy DN, Binh VQ, Duechting A, Kaiser H, Torresi J, Kandolf R, Bock CT. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol 2006, 45(3):361-369. 10.1016/j.jhep.2006.03.013, 16684578.
20. Wildig J, Cossart Y, Peshu N, Gicheru N, Tuju J, Williams TN, Newton CR. Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study. BMC Infect Dis 2010, 10:88. 10.1186/1471-2334-10-88, 2861060, 20361872.
21. Wildig J, Michon P, Siba P, Mellombo M, Ura A, Mueller I, Cossart Y. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis 2006, 194(2):146-153. 10.1086/505082, 16779719.
22. Yeats J, Daley H, Hardie D. Parvovirus B19 infection does not contribute significantly to severe anaemia in children with malaria in Malawi. Eur J Haematol 1999, 63(4):276-277.
23. Morinet F. Parvovirus B19 infection. Pathol Biol (Paris) 1992, 40(6):621-622.
24. Kalmbach Y, Boldt AB, Fendel R, Mordmuller B, Kremsner PG, Kun JF. Increase in annexin V-positive B cells expressing LILRB1/ILT2/CD85j in malaria. Eur Cytokine Netw 2006, 17(3):175-180.
25. Kun JF, Schmidt-Ott RJ, Lehman LG, Lell B, Luckner D, Greve B, Matousek P, Kremsner PG. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Trans R Soc Trop Med Hyg 1998, 92(1):110-114. 10.1016/S0035-9203(98)90979-8, 9692171.
26. Kun JF, Klabunde J, Lell B, Luckner D, Alpers M, May J, Meyer C, Kremsner PG. Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene. Gabon. Am J Trop Med Hyg 1999, 61(5):776-779.
27. Kun JF, Mordmuller B, Lell B, Lehman LG, Luckner D, Kremsner PG. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 1998, 351(9098):265-266. 10.1016/S0140-6736(05)78273-8, 9457101.
28. Kremsner PG, Radloff P, Metzger W, Wildling E, Mordmuller B, Philipps J, Jenne L, Nkeyi M, Prada J, Bienzle U, et al. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother 1995, 39(7):1603-1605. 10.1128/AAC.39.7.1603, 162790, 7492113.
29. Velavan TP, Buyukyazici B, Kremsner PG, Kun JF. Combined promoter haplotypes of the IL10R genes are associated with protection against severe malaria in Gabonese children. Immunogenetics 2012, 64(2):87-95. 10.1007/s00251-011-0563-3, 21814839.
30. Bultmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003, 34(1):92-95. 10.1053/hupa.2003.48, 12605372.
31. Toan NL, Duechting A, Kremsner PG, le Song H, Ebinger M, Aberle S, Binh VQ, Duy DN, Torresi J, Kandolf R, et al. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol 2006, 87(Pt 10):2941-2949.
32. Tschope C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 2005, 111(7):879-886. 10.1161/01.CIR.0000155615.68924.B3, 15710767.
33. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28(10):2731-2739. 10.1093/molbev/msr121, 3203626, 21546353.
34. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4(4):406-425.
35. Servant A, Laperche S, Lallemand F, Marinho V, De Saint MG, Meritet JF, Garbarg-Chenon A. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002, 76(18):9124-9134. 10.1128/JVI.76.18.9124-9134.2002, 136440, 12186896.
36. Freitas RB, Melo FL, Oliveira DS, Romano CM, Freitas MR, Macedo O, Linhares AC, De AZPM, Durigon EL. Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon region of Brazil. J Clin Virol 2008, 43(1):60-65. 10.1016/j.jcv.2008.03.033, 18502682.
37. Sanabani S, Neto WK, Pereira J, Sabino EC. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol 2006, 44(2):604-606. 10.1128/JCM.44.2.604-606.2006, 1392653, 16455922.
38. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, Tulloch S, Oldfield FS, Hayes R. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 1987, 81(3):478-486. 10.1016/0035-9203(87)90170-2, 3318021.
39. Menendez C, Fleming AF, Alonso PL. Malaria-related anaemia. Parasitol Today 2000, 16(11):469-476. 10.1016/S0169-4758(00)01774-9, 11063857.
40. Manning L, Laman M, Rosanas-Urgell A, Michon P, Aipit S, Bona C, Siba P, Mueller I, Davis TM. Severe anemia in Papua New Guinean children from a malaria-endemic area: a case-control etiologic study. PLoS Negl Trop Dis 2012, 6(12):e1972. 10.1371/journal.pntd.0001972, 3521670, 23272266.
41. Brown K. Anaemia, parvovirus, and malaria. Lancet 2006, 368(9537):714-716. 10.1016/S0140-6736(06)69265-9, 16935671.
42. Scarlata F, Gianelli E, Miceli S, Galimberti L, Antinori S. Acute parvovirus B19 infection and anemia during Plasmodium falciparum malaria. Clin Infect Dis 2002, 35(11):1449-1451. 10.1086/344452, 12439818.
43. Rios M, Bianco C. The role of blood group antigens in infectious diseases. Semin Hematol 2000, 37(2):177-185. 10.1016/S0037-1963(00)90042-8, 10791886.
44. Gupta R, Singh T. Parvovirus B19 co-infection with falciparum malaria: a cause of severe anemia. Haematologica 2005, 90(12 Suppl):ECR41.
45. Newton CR, Warn PA, Winstanley PA, Peshu N, Snow RW, Pasvol G, Marsh K. Severe anaemia in children living in a malaria endemic area of Kenya. Trop Med Int Health 1997, 2(2):165-178. 10.1046/j.1365-3156.1997.d01-238.x, 9472302.
46. Ho M, Webster HK, Looareesuwan S, Supanaranond W, Phillips RE, Chanthavanich P, Warrell DA. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis 1986, 153(4):763-771. 10.1093/infdis/153.4.763, 2936834.
47. Urganci N, Arapoglu M, Kayaalp N. Plasmodium falciparum malaria with coexisting parvovirus B19 infection. Indian Pediatr 2003, 40(4):369-370.
48. Candotti D, Etiz N, Parsyan A, Allain JP. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 2004, 78(22):12169-12178. 10.1128/JVI.78.22.12169-12178.2004, 525065, 15507603.
49. Opaleye OO, Fagbami AH, Lalremruata A, Kun JF. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria. J Med Virol 2011, 83(4):710-716. 10.1002/jmv.22008, 21328387.
50. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hubinger AM, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 2006, 103(19):7450-7453. 10.1073/pnas.0602259103, 1464359, 16651522.
51. Slavov SN, Kashima S, Silva-Pinto AC, Covas DT. Genotyping of Human parvovirus B19 among Brazilian patients with hemoglobinopathies. Can J Microbiol 2012, 58(2):200-205. 10.1139/w11-119, 22280886.